{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:54:29Z","timestamp":1771559669764,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.intimp.2023.109751","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000}}],"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202201ZYTS288"],"award-info":[{"award-number":["YDZJ202201ZYTS288"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20200201482JC"],"award-info":[{"award-number":["20200201482JC"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","award":["20220203130SF"],"award-info":[{"award-number":["20220203130SF"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.intimp.2023.109751","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T01:12:29Z","timestamp":1674522749000},"page":"109751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["WITHDRAWN: Interleukin-35 dampens T helper 22 phenotype shift in CD4+CD25+CD127dim\/- regulatory T cells in primary biliary cholangitis"],"prefix":"10.1016","author":[{"given":"Chen","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109751_b0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol Hepatol"},{"key":"10.1016\/j.intimp.2023.109751_b0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis","volume":"114","author":"Younossi","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.intimp.2023.109751_b0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1055\/s-0039-1697617","article-title":"The pathogenesis of primary biliary cholangitis: a comprehensive review","volume":"40","author":"Lleo","year":"2020","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.intimp.2023.109751_b0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cld.2022.06.003","article-title":"Immunologic responses and the pathophysiology of primary biliary cholangitis","volume":"26","author":"Chen","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.intimp.2023.109751_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpg.2018.05.008","article-title":"Evolution of our understanding of PBC","volume":"34\u201335","author":"Tanaka","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2023.109751_b0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/hepr.13318","article-title":"CD4(+) T cells from patients with primary biliary cholangitis show T cell activation and differentially expressed T-cell receptor repertoires","volume":"49","author":"Nakagawa","year":"2019","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.intimp.2023.109751_b0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2023.109751_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102619","article-title":"Regulatory T cells in autoimmune hepatitis: an updated overview","volume":"119","author":"Longhi","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.109751_b0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0050","first-page":"829","article-title":"Changes in peripheral blood 25 - hydroxyvitamin D(3), Th17 cells, and CD4(+) regulatory T cells and their clinical significance in patients with primary biliary cirrhosis","volume":"24","author":"Zhong","year":"2016","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.intimp.2023.109751_b0055","first-page":"3573","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Eyerich","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.109751_b0060","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"IL-22-producing \u201cT22\u201d T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humimm.2012.05.002","article-title":"The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naive CD4(+) Th cells to promote the development of IL-22-secreting Th cells","volume":"73","author":"Baba","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0070","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ni.1770","article-title":"Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells","volume":"10","author":"Trifari","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nature06306","article-title":"The inhibitory cytokine IL-35 contributes to regulatory T-cell function","volume":"450","author":"Collison","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.109751_b0080","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.109751_b0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12026-018-8998-3","article-title":"IL-35: a new immunomodulator in autoimmune rheumatic diseases","volume":"66","author":"Sakkas","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.intimp.2023.109751_b0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","article-title":"Emerging role of IL-35 in inflammatory autoimmune diseases","volume":"17","author":"Su","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2023.109751_b0100","unstructured":"S. Liu, Q. Zhang, M. Zhang, X. Zhong, W. Wang, L. Wang, et al. Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis. Bosn. J. Basic Med. Sci. doi: 10.17305\/bjbms.2022.8147(2022)."},{"key":"10.1016\/j.intimp.2023.109751_b0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.109751_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.109751_b0115","doi-asserted-by":"crossref","first-page":"e12657","DOI":"10.1111\/aji.12657","article-title":"The transdifferentiation of regulatory T and Th17 cells in autoimmune\/inflammatory diseases and its potential implications in pregnancy complications","volume":"78","author":"Liu","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2023.109751_b0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12985-019-1158-0","article-title":"Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim\/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection","volume":"16","author":"Yang","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.intimp.2023.109751_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108729","article-title":"Overexpression of ascitic interleukin-35 induces CD8(+) T cell exhaustion in liver cirrhotic patients with spontaneous bacterial peritonitis","volume":"108","author":"Yang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109751_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108161","article-title":"Interleukin-35 suppresses the activity of natural killer-like B cells in patients with hepatocellular carcinoma","volume":"100","author":"Liu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109751_b0140","article-title":"Interleukin-35 suppresses interleukin-9-secreting CD4(+) T cell activity in patients with hepatitis B-related hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0145","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1007\/s10620-020-06077-w","article-title":"Interleukin-35 suppresses CD8(+) T cell activity in patients with viral hepatitis-induced acute-on-chronic liver failure","volume":"65","author":"Yang","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.intimp.2023.109751_b0150","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3389\/fimmu.2019.01032","article-title":"Interleukin-35 dampens CD8(+) T cells activity in patients with non-viral hepatitis-related hepatocellular carcinoma","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0155","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fcimb.2017.00472","article-title":"Interleukin-35 suppresses antiviral immune response in chronic hepatitis B virus infection","volume":"7","author":"Shao","year":"2017","journal-title":"Front Cell Infect. Microbiol."},{"key":"10.1016\/j.intimp.2023.109751_b0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.intimp.2017.06.015","article-title":"An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection","volume":"50","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109751_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-011-0772-y","article-title":"Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention","volume":"353","author":"Zhang","year":"2011","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.intimp.2023.109751_b0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1517\/14728222.2013.736497","article-title":"Th22 and related cytokines in inflammatory and autoimmune diseases","volume":"17","author":"Tian","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2023.109751_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688066","article-title":"Role of Th22 cells in the pathogenesis of autoimmune diseases","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/sji.12057","article-title":"Expression of interleukin-22 in myasthenia gravis","volume":"78","author":"Zheng","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0185","doi-asserted-by":"crossref","first-page":"e31000","DOI":"10.1371\/journal.pone.0031000","article-title":"Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.109751_b0190","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s10875-011-9540-8","article-title":"Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis","volume":"31","author":"Zhang","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/1756-185X.12099","article-title":"IL-22+ CD4+ T cells in patients with rheumatoid arthritis","volume":"16","author":"Zhao","year":"2013","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.intimp.2023.109751_b0200","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1038\/s41598-017-05014-8","article-title":"Effector T helper cell populations are elevated in the bone marrow of rheumatoid arthritis patients and correlate with disease severity","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109751_b0205","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2023.109751_b0210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1155\/2013\/856056","article-title":"Serum levels of selected Th17 and Th22 cytokines in psoriatic patients","volume":"35","author":"Michalak-Stoma","year":"2013","journal-title":"Dis. Markers"},{"key":"10.1016\/j.intimp.2023.109751_b0215","first-page":"196","article-title":"An increased proportion of circulating Th22 and Tc22 cells in psoriasis","volume":"290","author":"Luan","year":"2014","journal-title":"CellImmunol"},{"key":"10.1016\/j.intimp.2023.109751_b0220","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.autrev.2013.11.008","article-title":"Interleukin-22: a likely target for treatment of autoimmune diseases","volume":"13","author":"Yang","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2023.109751_b0225","doi-asserted-by":"crossref","first-page":"3753081","DOI":"10.1155\/2018\/3753081","article-title":"The imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis","volume":"2018","author":"Liang","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2023.109751_b0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaut.2015.10.005","article-title":"AAV-IL-22 modifies liver chemokine activity and ameliorates portal inflammation in murine autoimmune cholangitis","volume":"66","author":"Hsueh","year":"2016","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.intimp.2023.109751_b0235","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12935-021-01766-6","article-title":"IRF4 overexpression promotes the transdifferentiation of tregs into macrophage-like cells to inhibit the development of colon cancer","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2023.109751_b0240","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2119\/molmed.2015.00057","article-title":"Pathogenic transdifferentiation of Th17 cells contribute to perpetuation of rheumatoid arthritis during anti-TNF treatment","volume":"21","author":"Andersson","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2023.109751_b0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3349\/ymj.2022.63.1.56","article-title":"Catalpol inhibits tregs-to-Th17 cell transdifferentiation by up-regulating let-7g-5p to reduce STAT3 protein levels","volume":"63","author":"Di","year":"2022","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.intimp.2023.109751_b0250","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.1601480","article-title":"Th22 cells form a distinct Th lineage from Th17 cells in vitro with unique transcriptional properties and Tbet-dependent Th1 plasticity","volume":"198","author":"Plank","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.109751_b0255","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2018.07.020","article-title":"Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-gamma secreting cells","volume":"94","author":"Liaskou","year":"2018","journal-title":"J. Autoimmun."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2023.109751","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:20:00Z","timestamp":1761567600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":51,"alternative-id":["S1567576923000747"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109751","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WITHDRAWN: Interleukin-35 dampens T helper 22 phenotype shift in CD4+CD25+CD127dim\/- regulatory T cells in primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109751"}}